Meeting
2024 ASCO Genitourinary Cancers Symposium
Identification and characterization of prognostic isoforms associated with bladder cancer outcomes.
Authors
Christopher Patsalis
University of Michigan, Ann Arbor, MI
Christopher Patsalis , Armand Bankhead III, Phillip Lee Palmbos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 683)
DOI
10.1200/JCO.2024.42.4_suppl.683
Abstract #
683
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2-breast cancer using real-world data.
First Author: Smita Agrawal
Poster
2018 Genitourinary Cancers Symposium
Role of mTORC2 and nitric oxide in bladder cancer invasion.
First Author: Divya Sahu
Poster
2014 Genitourinary Cancers Symposium
Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets.
First Author: Philip H. Kim
Poster
2011 ASCO Annual Meeting
Molecular studies support the association between germ-line genetic variants in the vascular endothelial growth factor (VEGF) pathway and survival in non-small cell lung cancer (NSCLC) patients.
First Author: D. M. Glubb